Delivery Order SPE2DB22D3301-SPE2DB24FZ2KB

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $13,822.85 and a completion date of January 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,503.49, is for the supply of Carvedilol ER 80 mg capsules. The contract has a completion date of February 3, 2025 and is a Firm Fixed Price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract has a ceiling value of $14,405.12 and a period of performance through July 2024. AmerisourceBergen, the prime contractor, will provide these prescription medications to support federal healthcare programs and agencies. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20mg capsules. The order has a firm fixed price of $8,163.29 and a completion date of September 5, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $18,940.52 and an ultimate completion date of September 11, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,680.79 contract is for the delivery of Carvedilol ER 80 mg capsules, a cardiovascular medication, with a completion date of December 3, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. The contract, valued at $1,923.96, is a firm fixed-price delivery order that will be completed by August 25, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,304.29 firm fixed-price contract is for the delivery of 4,563,458,616 units of the medication Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of January 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,326.03, is for the delivery of Carvedilol ER 80 mg capsules and has a completion date of March 28, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,459.41 firm fixed-price contract is for the delivery of 4566693051 - Carvedilol ER 20 mg capsules in 30-count packages. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2KB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 80 mg capsules. The contract, valued at $9,589.49, has an ultimate completion date of August 8, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. This delivery order is not associated with a set-aside program.

Generated 11/6/24, 9:15 AM